Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
1.650
+0.050 (3.13%)
At close: Dec 20, 2024, 4:00 PM
1.720
+0.070 (4.24%)
After-hours: Dec 20, 2024, 5:30 PM EST
Sana Biotechnology Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
328
Market Cap
368.39M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
ZimVie | 451.29M |
AngioDynamics | 292.73M |
Kamada | 158.38M |
Personalis | 87.49M |
REGENXBIO | 84.33M |
Delcath Systems | 22.64M |
Taysha Gene Therapies | 9.92M |
Prime Medicine | 800.00K |
SANA News
- 17 days ago - Sana: Major Inflection Point For SC291 In 2025 Targeting Lupus - Seeking Alpha
- 26 days ago - Sana Biotechnology to Present at December 2024 Investor Conferences - GlobeNewsWire
- 4 weeks ago - Sana Biotechnology: The Story Becomes Murkier - Seeking Alpha
- 6 weeks ago - Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 6 weeks ago - Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025 - GlobeNewsWire
- 2 months ago - Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference - GlobeNewsWire
- 4 months ago - Sana Biotechnology to Present at September 2024 Investor Conferences - GlobeNewsWire
- 4 months ago - Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer - GlobeNewsWire